What people are saying.

October 3, 2017

Gilead Sciences Completes Acquisition of Kite Pharma, Inc.

August 29, 2017

UroGen Pharma Receives FDA Fast Track Designation for MitoGel™ for the Treatment of Upper Tract Urothelial Carcinoma (UTUC)

August 28, 2017

Hubble Contacts Closes Series A-III Financing to Support Global Growth

August 28, 2017

Gilead Sciences to Acquire Kite Pharma for $11.9 Billion

August 8, 2017

Kite Submits Investigational New Drug (IND) Application for KITE-585, Anti-BCMA CAR-T Therapy Candidate for Multiple Myeloma

August 3, 2017

Kite Announces Landmark Study of Refractory Aggressive Non-Hodgkin Lymphoma (SCHOLAR-1) Outcomes Published in the Journal BLOOD

August 1, 2017

Sienna Biopharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

August 1, 2017

Cell Design Labs Appoints Roger Sidhu, M.D. As Chief Medical Officer